Safety and efficacy of PD-1 and PD-L1 inhibitors in relapsed and refractory Hodgkin's lymphoma: a systematic review and meta-analysis of 20 prospective studies - Sun, Chenxi; Chen, Huixian; Wang, Yongjing; Zheng, Chengyun (Hematology (Luxembourg), 2023)
Keywords: B7-H1 Antigen; camrelizumab; efficacy; Hodgkin Disease - drug therapy; Humans; Immune Checkpoint Inhibitors - adverse effects; Immune Checkpoint Inhibitors - therapeutic use; Leukopenia - chemically induced; meta-analysis; nivolumab; PD-1/PD-L1 inhibitors; pembrolizumab; Programmed Cell Death 1 Receptor; Prospective Studies; relapsed and refractory Hodgkin's lymphoma; safety; relapsed and refractory Hodgkin's lymphoma; pembrolizumab; nivolumab; safety; meta-analysis; PD-1/PD-L1 inhibitors; efficacy; camrelizumab